<DOC>
	<DOC>NCT01076959</DOC>
	<brief_summary>To clarify the following matters: - Unknown adverse reactions (especially clinically significant adverse reactions) - Incidence and conditions of occurrence of adverse reactions in the clinical setting - Factors that may affect the safety and effectiveness of Humira</brief_summary>
	<brief_title>Drug Use Investigation for HumiraÂ® - All Patient Investigation for Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>All patients prescribed and treated with Humira are included in this survey. Contraindications according to the Package Insert: Patients who have serious infections, Patients who have tuberculosis, Patients with a history of hypersensitivity to any ingredient of Humira, Patients who have demyelinating disease or with a history of demyelinating disease, Patients who have cardiac failure congestive.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>